Literature DB >> 34980865

Consequences of hyperandrogenemia during pregnancy in female offspring: attenuated response to angiotensin II.

Noha M Shawky1,2,3, Carolina Dalmasso4, Norma B Ojeda5,2,3, Yvonne Zuchowski1,2,3, Nina Stachenfeld6, Barbara T Alexander7,2,3, Jane F Reckelhoff1,2,3.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is characterized by reproductive and metabolic dysfunction, and elevated blood pressure (BP). The cardiometabolic consequences of maternal hyperandrogenemia on offspring, either as adults or with aging, have not been well studied. We previously found that male offspring of hyperandrogenemic female (HAF) rats, a model of PCOS, are normotensive but have an exaggerated pressor response to angiotensin (Ang) II.
METHOD: In this study, the hypothesis was tested that adult and aging female offspring of HAF rats develop a metabolic and hypertensive phenotype. Control and HAF rats were implanted prepubertally with placebo or dihydrotestosterone pellets, which continued throughout pregnancy and lactation.
RESULTS: Female offspring of HAF dams had lower birth weight than female control offspring. Although female HAF offspring (aged 16-24 weeks) had no differences in intrarenal Ang II, plasma lipids or proteinuria, they did have lower intrarenal Ang (1-7) and lower nitrate/nitrite excretion than controls. Adult HAF offspring had similar baseline BP as controls, but had an attenuated pressor response to Ang II. With aging (16-20 months), female HAF offspring remained normotensive with an attenuated pressor response to Ang II and high salt diet but more proteinuria and higher intrarenal Ang(1-7) than controls.
CONCLUSION: Taken together, these data suggest that female HAF offspring are protected from developing hypertension, but may be at risk for renal injury with aging. Future studies are necessary to determine whether adult and postmenopausal offspring of PCOS women are at increased risk for cardiovascular dysfunction.Graphical abstract:http://links.lww.com/HJH/B820.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34980865      PMCID: PMC8897268          DOI: 10.1097/HJH.0000000000003067

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  55 in total

1.  Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide.

Authors:  Tanya M Gwathmey; Brian M Westwood; Nancy T Pirro; Lijun Tang; James C Rose; Debra I Diz; Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-01

2.  Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis.

Authors:  Lucinda E Kjerulff; Luis Sanchez-Ramos; Daniel Duffy
Journal:  Am J Obstet Gynecol       Date:  2011-03-16       Impact factor: 8.661

3.  ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

Authors:  Carlos Díez-Freire; Jorge Vázquez; María F Correa de Adjounian; Merari F R Ferrari; Lihui Yuan; Xeve Silver; Raquel Torres; Mohan K Raizada
Journal:  Physiol Genomics       Date:  2006-06-20       Impact factor: 3.107

Review 4.  Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome.

Authors:  Irene Lambrinoudaki
Journal:  Maturitas       Date:  2010-10-12       Impact factor: 4.342

5.  Subpressor dose of angiotensin II increases susceptibility to the haemodynamic injury of blood pressure in Dahl salt-sensitive rats.

Authors:  N Hirawa; Y Uehara; Y Kawabata; A Numabe; N Ohshima; H Ono; T Gomi; T Ikeda; S Yagi; T Toyo-oka
Journal:  J Hypertens       Date:  1995-01       Impact factor: 4.844

6.  Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.

Authors:  A T Hirsch; C E Talsness; A D Smith; H Schunkert; J R Ingelfinger; V J Dzau
Journal:  Circulation       Date:  1992-11       Impact factor: 29.690

7.  Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging.

Authors:  J F Reckelhoff; J A Kellum; E J Blanchard; E E Bacon; A J Wesley; W C Kruckeberg
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

8.  Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome.

Authors:  Teresa Sir-Petermann; Ethel Codner; Virginia Pérez; Bárbara Echiburú; Manuel Maliqueo; Amanda Ladrón de Guevara; Jessica Preisler; Nicolás Crisosto; Fernando Sánchez; Fernando Cassorla; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2009-02-17       Impact factor: 5.958

Review 9.  Blood pressure in postmenopausal women with a history of polycystic ovary syndrome.

Authors:  Katarzyna Doroszewska; Tomasz Milewicz; Sandra Mrozińska; Jarosław Janeczko; Radosław Rokicki; Marek Janeczko; Damian Warzecha; Piotr Marianowski
Journal:  Prz Menopauzalny       Date:  2019-06-14

10.  Consequences of advanced aging on renal function in chronic hyperandrogenemic female rat model: implications for aging women with polycystic ovary syndrome.

Authors:  Chetan N Patil; Lorraine C Racusen; Jane F Reckelhoff
Journal:  Physiol Rep       Date:  2017-11
View more
  1 in total

Review 1.  Polycystic Ovary Syndrome: Insights from Preclinical Research.

Authors:  Jane F Reckelhoff; Noha M Shawky; Damian G Romero; Licy L Yanes Cardozo
Journal:  Kidney360       Date:  2022-06-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.